'Hims & Hers unlocks access to injectable GLP-1 medications, expanding its holistic weight loss program focused on personalized and affordable solutions; prices start as low as $199 a month.'
This explains why the $HIMS CEO was also very confident leading up to earnings and during his earnings call.
They knew the product they had and what was in the pipeline.
Share price has jumped +10% in the PM which puts our gains on our buy alerts above +40% since the start of May.
A break above the previous high at $17.16 confirms Wave 3 for me but I believe we are comfortably in it in now.
Even there is a possibility to retest the 50 Day MA at $14 at any stage and holds, then you have a buy signal to add.